 |
 |

Addressing the Long-term Safety Aspects of Butterbur Therapy: A Call for Immediate ActionReply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply
Dr Lee has raised an important point regarding the long-term safety of butterbur therapy. To my knowledge, the longest (published) treatment period with any butterbur preparation has been 16 weeks.1 Normally, this length of time would be sufficient for the treatment of a seasonal condition such as intermittent allergic rhinitis. However, the fact remains that formal long-term safety data are lacking and are urgently needed. Until such data are available, and in view of the excellent results in short-term studies, my colleagues and I have limited our use of butterbur (leaf extract) to short-term treatments of no more than 16 weeks (typically 8-12 weeks), according to patient response and tolerability. Importantly, long-term data, when obtained, may not be transferable to all butterbur formulations, as the toxicity potential of root extracts as used in some of the published studies (compare references 3-5 in Dr Lee's letter and reference 1 . . . [Full Text of this Article] AUTHOR INFORMATION
Andreas Schapowal, MD, PhD, DSc, Hon
RELATED ARTICLES
Addressing the Long-term Safety Aspects of Butterbur Therapy: A Call for Immediate Action
Daniel K. C. Lee
Arch Otolaryngol Head Neck Surg. 2005;131(6):539-540.
EXTRACT
| FULL TEXT
Contact Information
Arch Otolaryngol Head Neck Surg. 2005;131(6):544.
EXTRACT
| FULL TEXT
|